Economy · World
Novo Nordisk Considers US Stock Exchange Listing
Novo Nordisk, the maker of Ozempic, is open to upgrading its US stock listing, according to CEO Mike Doustdar. He stated that there are "advantages" to giving US investors direct access to the Danish company's stock. Doustdar conveyed this to the Financial Times.
How outlets across the spectrum covered it
L 0 C 2 R 0
- Centre (2): Financial Times, Reuters